Biotech · Private company
MitoImmune Therapeutics
Track this companyFree. Adds MitoImmune Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- MIT-001 plus CCRTPhase 2 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- MIT-001 for Prevention of CCRT-Induced OM in HNSCC PatientsPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 21, 2021ClinicalTrials.gov NCT04651634 · fetched Nov 12, 2026